191 related articles for article (PubMed ID: 23348212)
21. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
22. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
Bourdeaut F; Chi SN; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
24. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
25. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
[TBL] [Abstract][Full Text] [Related]
26. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
Agaimy A
Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
[TBL] [Abstract][Full Text] [Related]
27. Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.
Carlo MI; Chaim J; Patil S; Kemel Y; Schram AM; Woo K; Coskey D; Nanjangud GJ; Voss MH; Feldman DR; Hsieh JJ; Hakimi AA; Chen YB; Motzer RJ; Lee CH
Clin Genitourin Cancer; 2017 Dec; 15(6):e987-e994. PubMed ID: 28558987
[TBL] [Abstract][Full Text] [Related]
28. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity.
Medeiros LJ; Palmedo G; Krigman HR; Kovacs G; Beckwith JB
Am J Surg Pathol; 1999 Jul; 23(7):772-80. PubMed ID: 10403299
[TBL] [Abstract][Full Text] [Related]
29. Renal medullary carcinoma in a young mixed-race man in Japan.
Toriyama A; Izumi H; Tomita S; Nagashima Y; Ueda Y; Aoki Y; Tsujimura A; Yao T; Hino O
Pathol Int; 2019 Apr; 69(4):241-245. PubMed ID: 30843648
[TBL] [Abstract][Full Text] [Related]
30. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
Pivovarcikova K; Peckova K; Martinek P; Montiel DP; Kalusova K; Pitra T; Hora M; Skenderi F; Ulamec M; Daum O; Rotterova P; Ondic O; Dubova M; Curik R; Dunatov A; Svoboda T; Michal M; Hes O
Virchows Arch; 2016 Jul; 469(1):71-80. PubMed ID: 27072821
[TBL] [Abstract][Full Text] [Related]
31. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract][Full Text] [Related]
32. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; De Nictolis M; Santoni M; Montironi R
Pathology; 2014 Dec; 46(7):653-5. PubMed ID: 25393261
[No Abstract] [Full Text] [Related]
34. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
35. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
[TBL] [Abstract][Full Text] [Related]
36. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.
Renshaw AA; Granter SR; Fletcher JA; Kozakewich HP; Corless CL; Perez-Atayde AR
Am J Surg Pathol; 1999 Jul; 23(7):795-802. PubMed ID: 10403302
[TBL] [Abstract][Full Text] [Related]
38. Epithelioid sarcoma of the parotid gland of a child.
Keelawat S; Shuangshoti S; Kittikowit W; Lerdlum S; Thorner PS
Pediatr Dev Pathol; 2009; 12(4):301-6. PubMed ID: 19335024
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in Renal Medullary Carcinoma.
Su Y; Hong AL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
